The pH-independent release of fenoldopam from pellets with insoluble film coats

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 46, Issue 1, 1998, Pages 105-113

  Thoma, Karl ^a   Ziegler, Iris ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Kinetic models; Succinic acid and fumaric acid as pH adjuster; Surelease; Sustained release; Weakly basic drug

Indexed keywords

CELLULOSE ACETATE; DODECYL SULFATE SODIUM; ETHYL CELLULOSE; FENOLDOPAM; FUMARIC ACID; OPADRY CLEAR OY 29020; SUCCINIC ACID; UNCLASSIFIED DRUG; WETTING AGENT;

ARTICLE; DISPERSION; DISSOLUTION; DRUG COATING; DRUG PELLET; DRUG RELEASE; DRUG SOLUBILITY; KINETICS; PH; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION;

CHEMISTRY, PHARMACEUTICAL; DOPAMINE AGONISTS; FENOLDOPAM; HYDROGEN-ION CONCENTRATION; PHARMACEUTIC AIDS; SUCCINIC ACID; TABLETS;

EID: 0032409889     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00164-1     Document Type: Article

References (17)

1. Thoma K., Zimmer Th. Retardierung schwach basischer Arzneistoffe. 1. Mitt.: Behebung der Verfügbarkeitsprobleme von Noscapin aus Diffusionspellets. Pharm. Ind. 51(1):1989;98-101.
2. Thoma K., Zimmer Th. Retardation of weakly basic drugs with diffusion tablets. Int. J. Pharm. 58:1990;197-202.
3. Thoma K., Zimmer Th. Retardierung schwach basischer Arzneistoffe. 2. Mitt.: Verbesserung der Verfügbarkeit von Papaverin und Codein aus Diffusionspellets. Pharm. Ind. 51(5):1989;540-543.
4. R.J. Timko, N.G. Lordi, In vitro evaluation of three commercial sustained release papaverine hydrochloride products, J. Pharm. Sci. 67 (1978) 496-500.
5. Healy A.M., Corrigan O.I. Predicting the dissolution rate of ibuprofen-acidic excipient compressed mixtures in reactive media. Int. J. Pharm. 84:1992;167-173.
6. Gabr K.E. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur. J. Pharm. Biopharm. 38(6):1992;199-202.
7. Nichols A.J., Ruffolo R.R. Jr., Brooks D.P. The pharmacology of fenoldopam. Am. J. Hypertens. 3(6 Pt 2):1990;116S-119S.
8. Dissolution assay for fenoldopam mesylate extended release capsules using high performance liquid chromatography, SmithKline Beecham internal documents.
9. V.K. Boppana, R.C. Heineman, R.K. Lynn, A.P. Intoccia, J.A. Ziemniak, Pharmacokinetics of fenoldopam mesylate (SK and F 82526-J) in healthy volunteers after oral administration, SK Beecham internal studies.
10. I. Ziegler, Investigations on the sustained release of fenoldopam from film coated pellets for an oral dosage form, PhD. thesis, Munich, 1996.
11. J.B. Dressman, B.O. Palsson, A. Ozturk, S. Ozturk, Mechanisms of release from coated pellets, in: Drugs and the Pharmaceutical Sciences, Vol. 67, Multiparticulate Oral Drug Delivery, Marcel Dekker, New York, 1994, pp. 285-306.
12. R.E. O'Connor, J.B. Schwartz, Extrusion and spheronization technology, in: Drugs and the Pharmaceutical Sciences, Vol. 37, Pharmaceutical Pelletization Technology, Marcel Dekker, New York, 1989, pp. 187-216.
13. Hixon A.W., Crowell J.H. Dependence of reaction velocity upon surface and agitation. Ind. Engin. Chem. 23:1931;923-930.
14. Jander W. Reaktionen im festen Zustande bei höheren Temperature. Anorg. Allgem. Chem. 163:1927;1-30.
15. Bergensen K., Jacobsen L. Factorial design used for ruggedness testing of flow through cell dissolution method by means of Weibull transformed drug release profiles. Int. J. Pharm. 88(1-3):1992;23-29.
16. Bianchini R., Bruni G., Gazzaniga A., Vecchio C. Extended-release pellets prepared by coating with aqueous polymer dispersions. Drug Dev. Ind. Pharm. 19(16):1993;2021-2041.
17. C. Lorck, Überziehen von Pellets zu Retardarzneiformen, presented at 'Wäßrige Filmüberzüge für feste Arzneiformen', APV Kurs 156, Darmstadt 1995.